NovaQuest Capital Management, the corporate venturing unit which was spun off from US-based healthcare provider Quintiles Transnational in 2010, has raised $80 million for a new fund, NovaQuest Co- Investment Fund I, LP, according to a regulatory filing on 3 May.

Novaquest’s existing fund, NovaQuest Pharma Opportunities Fund III, LP, launched in November 2010, had raised $426.1m against its $500m target offering, as of its latest regulatory filing on 14 November 2012.  In the most recent investment for the fund,…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?